Pharma News

FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder

Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia.

Source link
#FDA #Approves #Vanda #Pharmaceuticals039 #Fanapt #Treat #Adults #Bipolar #Disorder

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *